血小板衍生的脂质促进胰腺β细胞的胰岛素分泌
Till Karwen1, Katarzyna Kolczynska-Matysiak2, Carina Gross3
1Rudolf Virchow Center for Integrative and Translational Bioimaging, Julius-Maximilians University of Würzburg, Würzburg, Germany.
EMBO molecular medicine
|July 25, 2023
概括
血小板通过刺激胰腺β细胞来调节新陈代谢. 这项研究揭示了血小板衍生的20-HETE促进胰岛素分泌,这对年轻人葡萄糖平衡至关重要.
科学领域:
- 代谢研究的研究.
- 血液学 血液学 血液学
- 内分泌学 在内分泌学.
背景情况:
- 超反应性血小板在糖尿病中很常见,这表明血糖控制和血小板功能之间存在联系.
- 血小板可能在调节全身新陈代谢,特别是葡萄糖平衡中发挥作用.
- 胰腺β细胞是葡萄糖平衡的关键调节者.
研究的目的:
- 研究血小板在调节胰腺β细胞功能和葡萄糖平衡中的作用.
- 为了识别影响血小板活动的来自β细胞的特定因素.
- 探索血小板功能对胰岛素分泌和葡萄糖耐受性的影响.
主要方法:
- 研究了刺激血小板活动的β细胞衍生因素.
- 检查了胰腺小岛内的血小板局部.
- 在血小板枯竭或途径废除后评估葡萄糖耐受性和胰岛素水平.
- 分析了血小板衍生的脂类,包括20-Hydroxyeicosatetraenoic acid (20-HETE),以了解它们对胰岛素分泌的影响.
主要成果:
- 贝塔细胞因子刺激血小板活动;血小板局部化到胰腺小岛血管系统.
- 血小板枯竭或途径中断会损害葡萄糖耐受性,降低胰岛素水平.
- 血小板衍生的脂质,特别是20-HETE,增强胰岛素分泌和β细胞功能.
- 血小板衍生的20-HETE水平随着年龄的增长而下降,与β细胞功能减弱相关.
结论:
- 血小板意外地调节胰岛素分泌和葡萄糖代谢.
- 血小板衍生的20-HETE是促进β细胞功能和代谢健康的关键因素.
- 这种血小板-β细胞相互作用对于维持新陈代谢健康至关重要,特别是在年轻人中.
相关概念视频
Insulin Secretory Vesicles
5.0K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
5.0K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.3K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.3K
Insulin: Biosynthesis, Chemistry, and Preparation
432
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
432
Hormones Regulating Blood Glucose
3.5K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.5K
Insulin: The Receptor and Signaling Pathways
1.3K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.3K
Glucagon-like Receptor Agonists
358
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
358


